Directory
>
Annie Chen
Annie Chen
Strategic Consultant
Boston, Massachusetts, United States
Annie Chen
Summary
Annie Chen is a seasoned Biotech Executive with extensive experience in clinical research and medical leadership. She currently serves as a Board Member at Jnana Therapeutics, where she leverages her strategic insights for the advancement of therapeutic innovations. With a robust background that includes positions such as Chief Medical Officer at Nimbus Therapeutics and Executive Director at Merck, Annie has a proven track record in guiding organizations through complex medical landscapes. Her academic credentials from prestigious institutions like Harvard and UCSF complement her practical expertise, making her a valuable asset in the biotech sector. Annie is also known for her commitment to mentoring emerging leaders in the industry, reflecting her passion for leadership development. Her unique blend of clinical and strategic knowledge positions her as a thought leader in biotechnology.
Annie Chen
Work Experience
Strategic Consultant at
Double Spring Biopharma Consulting LLC
June 2021 - Present
Board Member at
Jnana Therapeutics
October 2020 - September 2024
Chief Medical Officer & President Tyk2 Subsidiary at
Nimbus Therapeutics
January 2015 - January 2021
Consultant Chief Medical Officer at
Delinia
October 2016 - February 2017
Executive Director, Clinical Research at
Merck
January 2010 - January 2015
Senior Medical Director at
Genentech Foundation
January 2006 - January 2010
Assistant Clinical Professor of Medicine at
UCSF Health
January 2003 - January 2010
Medical Director at
Celera Corporation
January 2003 - January 2006
Annie Chen
Education
Frequently Asked Questions about Annie Chen
Where Annie Chen graduated from?
Annie Chen holds a degree in from Harvard University.
Who is Annie Chen?
Annie Chen is a seasoned Biotech Executive with extensive experience in clinical research and medical leadership. She currently serves as a Board Member at Jnana Therapeutics, where she leverages her strategic insights for the advancement of therapeutic innovations. With a robust background that includes positions such as Chief Medical Officer at Nimbus Therapeutics and Executive Director at Merck, Annie has a proven track record in guiding organizations through complex medical landscapes. Her academic credentials from prestigious institutions like Harvard and UCSF complement her practical expertise, making her a valuable asset in the biotech sector. Annie is also known for her commitment to mentoring emerging leaders in the industry, reflecting her passion for leadership development. Her unique blend of clinical and strategic knowledge positions her as a thought leader in biotechnology.
Annie`s contact details